Posters

Clinical efficacy and safety of immediate manual Meibomian gland expression after thermal pulsation (LipiFlow) for post-LASIK obstructive Meibomian gland obstruction

Poster Details

First Author: J.Park SOUTH KOREA

Co Author(s):    J. Rhim   C. Im                 

Abstract Details

Purpose:

To evaluate clinical efficacy and safety of immediate manual meibomian gland expression (MGX) after thermal pulsation (LipiFlow) for Post LASIK obstructive meibomian gland obstruction.

Setting:

Retrospective case series

Methods:

Patients who underwent immediate manual MGX after LipiFlow for Post LASIK Obstructive MGD were included. 20 eyes of 10 patients were enrolled. All patients underwent 3 times of treatment at a monthly. All patients were followed for 6 months. All patients were examined before, 3 and 6 months after treatments. Investigation included Ocular Surface Disease Index (OSDI) Score, non-invasive tearfilm break-up time (NIBUT), lipid layer thickness (LLT) by LipiView, corneal and conjunctival staining, and tear meniscus height.

Results:

There were a significant improvement in NIBUT, LLT and OSDI score at 3 months. And the improvement of NIBUT, LLT and OSDI score at 3 months were maintained up to 6 months. NIBUT was slightly deteriorated at 6 months. However, there was no statistical significant. During the follow-up period, no adverse events developed.

Conclusions:

mmediate MGX after LipiFlow are clinically effective and safe in Post LASIK obstructive MGD. This combination procedure demonstrates improvements in efficacy over conventional methods.

Financial Disclosure:

None